330 related articles for article (PubMed ID: 11757205)
1. Overview of hypercalcemia of malignancy.
Solimando DA
Am J Health Syst Pharm; 2001 Nov; 58 Suppl 3():S4-7. PubMed ID: 11757205
[TBL] [Abstract][Full Text] [Related]
2. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of hypercalcaemia of malignancy.
Mundy GR
Clin Endocrinol (Oxf); 1985 Dec; 23(6):705-14. PubMed ID: 3006948
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of bone resorption and renal tubular reabsorption of calcium and phosphate in malignant and nonmalignant hypercalcemia.
Buchs B; Rizzoli R; Bonjour JP
Bone; 1991; 12(1):47-56. PubMed ID: 2054236
[TBL] [Abstract][Full Text] [Related]
5. Hypercalcemia and cancer: an update.
Murray TM; Josse RG; Heersche JN
Can Med Assoc J; 1978 Oct; 119(8):915-20. PubMed ID: 367555
[TBL] [Abstract][Full Text] [Related]
6. Hypercalcemia induced with the plasma levels of parathyroid hormone-related peptide in multiple myeloma.
Shionoiri A; Horiuchi T; Onouchi T; Tsutsumi H; Ohta M; Hosoi T; Ito H; Orimo H
Intern Med; 2000 Oct; 39(10):810-3. PubMed ID: 11030205
[TBL] [Abstract][Full Text] [Related]
7. The combined effect of tumor-produced parathyroid hormone-related protein and transforming growth factor-alpha enhance hypercalcemia in vivo and bone resorption in vitro.
Guise TA; Yoneda T; Yates AJ; Mundy GR
J Clin Endocrinol Metab; 1993 Jul; 77(1):40-5. PubMed ID: 8325957
[TBL] [Abstract][Full Text] [Related]
8. Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancy.
Rizzoli R; Thiébaud D; Bundred N; Pecherstorfer M; Herrmann Z; Huss HJ; Rückert F; Manegold C; Tubiana-Hulin M; Steinhauer EU; Degardin M; Thürlimann B; Clemens MR; Eghbali H; Body JJ
J Clin Endocrinol Metab; 1999 Oct; 84(10):3545-50. PubMed ID: 10522993
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone-related protein-(1--36) stimulates renal tubular calcium reabsorption in normal human volunteers: implications for the pathogenesis of humoral hypercalcemia of malignancy.
Syed MA; Horwitz MJ; Tedesco MB; Garcia-Ocaña A; Wisniewski SR; Stewart AF
J Clin Endocrinol Metab; 2001 Apr; 86(4):1525-31. PubMed ID: 11297578
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.
Uy HL; Mundy GR; Boyce BF; Story BM; Dunstan CR; Yin JJ; Roodman GD; Guise TA
Cancer Res; 1997 Aug; 57(15):3194-9. PubMed ID: 9242449
[TBL] [Abstract][Full Text] [Related]
11. [Hypercalcemia].
Schmid C
Schweiz Med Wochenschr; 1994 Jun; 124(25):1122-8. PubMed ID: 8029686
[TBL] [Abstract][Full Text] [Related]
12. [Hypocalcemia in malignant diseases].
Heidbreder E; Schafferhans K; Heidland A
Klin Wochenschr; 1983 Aug; 61(16):773-83. PubMed ID: 6355639
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
[TBL] [Abstract][Full Text] [Related]
14. Cinacalcet attenuates hypercalcemia observed in mice bearing either Rice H-500 Leydig cell or C26-DCT colon tumors.
Colloton M; Shatzen E; Wiemann B; Starnes C; Scully S; Henley C; Martin D
Eur J Pharmacol; 2013 Jul; 712(1-3):8-15. PubMed ID: 23623934
[TBL] [Abstract][Full Text] [Related]
15. [Tumoral hypercalcemia: physiopathology and treatment].
Rizzoli R; Jung A; Bonjour JP
Schweiz Med Wochenschr; 1985 Mar; 115(10):326-32. PubMed ID: 3157214
[TBL] [Abstract][Full Text] [Related]
16. Significance of parathyroid hormone-related protein as a factor stimulating bone resorption and causing hypercalcemia in myeloma.
Tsujimura H; Nagamura F; Iseki T; Kanazawa S; Saisho H
Am J Hematol; 1998 Oct; 59(2):168-70. PubMed ID: 9766803
[TBL] [Abstract][Full Text] [Related]
17. [The role of a parathyroid hormone analogue in the pathogenesis of malignant hypercalcemia].
Rizzoli R; Buchs B; Pizurki L; Caverzasio J; Sappino AP; Vadas L; Arlot M; Bonjour JP
Pathol Biol (Paris); 1990 Jun; 38(6):656-64. PubMed ID: 2197594
[TBL] [Abstract][Full Text] [Related]
18. Hyperparathyroidism, humoral hypercalcemia of malignancy, and the anabolic actions of parathyroid hormone and parathyroid hormone-related protein on the skeleton.
Stewart AF
J Bone Miner Res; 2002 May; 17(5):758-62. PubMed ID: 12009005
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid hormone-related protein induced coupled increases in bone formation and resorption markers for 7 years in a patient with malignant islet cell tumors.
Takeuchi Y; Fukumoto S; Nakayama K; Tamura Y; Yanagisawa A; Fujita T
J Bone Miner Res; 2002 May; 17(5):753-7. PubMed ID: 12009004
[TBL] [Abstract][Full Text] [Related]
20. Primary hyperparathyroidism and parathyroid hormone-related protein.
Horwitz MJ; Bilezikian JP
Curr Opin Rheumatol; 1994 May; 6(3):321-8. PubMed ID: 8060769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
